Literature DB >> 10442586

The otolaryngologic manifestations of gastroesophageal reflux: when is a pH study indicated?

S Bouchard1, M Lallier, S Yazbeck, A Bensoussan.   

Abstract

PURPOSE: The aim of this study was to evaluate the pertinence of pH studies for persistent ear, nose, and throat (ENT) symptoms and their eventual relationship to gastroesophageal reflux (GER).
METHODS: Retrospective analysis was performed of age, reason for referral, pH study, treatment, and follow-up of patients with ENT symptoms suspected to have GER.
RESULTS: Of 3,000 esophageal pH studies performed over 16 years, 105 children were referred for ENT symptoms by an otorhinolaryngologist to rule out GER. Mean age was 33 months; 65% were boys. Reasons for referral included (number and mean age): stridor (n = 31, 8 months), laryngomalacia (n = 18, 13 months), recurrent otitis (n = 12, 42 months), laryngitis (n = 16, 50 months), dysphonia (n = 14, 59 months), laryngeal papillomatosis (n = 8, 62 months), sinusitis (n = 5, 56 months), and dysphagia (n = 1). Overall, 41% of study results were positive: stridor (58%), laryngomalacia (61%), laryngitis (56%) and sinusitis (40%). Patients with otitis, dysphonia and laryngeal papillomatosis had GER in 1%, 14%, and 25%, respectively. Follow-up in the three larger groups of patients showed resolution of the ENT symptoms after medical treatment of the reflux in 83% of patients with stridor and reflux, 86% with laryngitis and reflux, and 80% with laryngomalacia and reflux. Four fundoplications were performed: one neurologically impaired patient, and four nonresponders.
CONCLUSIONS: The authors recommend that a pH study be performed in children with stridor, laryngomalacia, laryngitis, and sinusitis when faced with failure of the usual treatment. However, a pH study does not seem as beneficial for recurrent otitis, dysphonia, or laryngeal papillomatosis.

Entities:  

Mesh:

Year:  1999        PMID: 10442586     DOI: 10.1016/s0022-3468(99)90562-6

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  10 in total

1.  Reflux of nasopharyngeal content into middle ear through the eustachian tube.

Authors:  Elif Ayanoglu; Cuneyd Uneri; Turgut Turoglu; Varlik Dogan
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-11-18       Impact factor: 2.503

Review 2.  Pediatric otolaryngologic manifestations of gastroesophageal reflux disease.

Authors:  Mark A Gilger
Journal:  Curr Gastroenterol Rep       Date:  2003-06

3.  [Gastroesophageal reflux (GER)--cause of otitis media with effusion in childhood?].

Authors:  H Sudhoff; S Euteneuer; S Dazert; A Schmidt-Choudhury; S Schreiber
Journal:  HNO       Date:  2004-01       Impact factor: 1.284

Review 4.  ENT manifestations of gastro-oesophageal reflux in children.

Authors:  G Caruso; F M Passali
Journal:  Acta Otorhinolaryngol Ital       Date:  2006-10       Impact factor: 2.124

Review 5.  The frontiers of reflux disease.

Authors:  Nimish Vakil
Journal:  Dig Dis Sci       Date:  2006-09-29       Impact factor: 3.199

6.  [Stenosing gastric laryngitis in infancy].

Authors:  A Hennig; A Neumann; H-J Schultz-Coulon
Journal:  HNO       Date:  2004-04       Impact factor: 1.284

7.  [The need for 24-h double probe pH monitoring in the diagnosis of laryngo-pharyngeal reflux].

Authors:  P Jecker; R Schuon; W J Mann
Journal:  HNO       Date:  2003-04-09       Impact factor: 1.284

8.  Anti-reflux procedure for difficult-to-treat asthmatic children, case report and literature review.

Authors:  Zhi-Wei Hu; Zhong-Gao Wang; Ji-Min Wu; Song-Tao Tan
Journal:  Multidiscip Respir Med       Date:  2012-09-14

9.  Reconstructive procedures for impaired upper airway function: laryngeal respiration.

Authors:  Andreas Müller
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2005-09-28

10.  A preliminary investigation of anti-reflux intervention for gastroesophageal reflux related childhood-to-adult persistent asthma.

Authors:  Zhi Wei Hu; Zhong Gao Wang; Yu Zhang; Ji Min Wu; Wei Tao Liang; Yue Yang; Shu Rui Tian; Ai E Wang
Journal:  Ann Surg Innov Res       Date:  2014-06-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.